Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38771876)
Watch
English
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
scientific article published on 10 May 2016
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
title
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
(English)
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
author
Leena Karhinen
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Sawan Kumar Jha
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Tero Aittokallio
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Krister Wennerberg
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Agnieszka Szwajda
series ordinal
3
object named as
Agnieszka Szwajda
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
author name string
Prson Gautam
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Bhagwan Yadav
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
publication date
10 May 2016
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
published in
Molecular Cancer
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
volume
15
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
page(s)
34
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
exact match
https://scigraph.springernature.com/pub.10.1186/s12943-016-0517-3
0 references
cites work
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Organoids as an in vitro model of human development and disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The proteomic landscape of triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Targeting a cell state common to triple-negative breast cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Evaluation of impermeant, DNA-binding dye fluorescence as a real-time readout of eukaryotic cell toxicity in a high throughput screening format
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
New strategies for triple-negative breast cancer--deciphering the heterogeneity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
A New Bliss Independence Model to Analyze Drug Combination Data
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Inconsistency in large pharmacogenomic studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Modeling precision treatment of breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Comprehensive molecular portraits of human breast tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Systematic identification of genomic markers of drug sensitivity in cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Subtype and pathway specific responses to anticancer compounds in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
A multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Triple negative breast cancer: unmet medical needs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Protein kinase C isoforms: Multi-functional regulators of cell life and death
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Targeting the ubiquitin-proteasome pathway in breast cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Developing in vitro models of human ductal carcinoma in situ from primary tissue explants
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
6 September 2017
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Prediction of anticancer drug potency from expression of genes involved in growth factor signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
14 September 2017
Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
25 September 2017
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
23 June 2018
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
31 August 2018
Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
31 August 2018
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
31 August 2018
The STAT3 oncogene as a predictive marker of drug resistance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862054
retrieved
31 August 2018
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27165605
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/S12943-016-0517-3
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Dimensions Publication ID
1017969278
0 references
PMCID
4862054
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
PubMed ID
27165605
1 reference
stated in
Europe PubMed Central
PMCID
4862054
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27165605%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit